GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0001966698-26-000002
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-20.83K
Net shares
Net seller
$409.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
20.83K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−20.83K
Price / share
$19.66
Trade value
$409.58K
% of position
5.9%
2/20/2026
355.28K→334.45K
Total
Net shares
−20.83K
Net value
-$409.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2026 | F · Tax Withholding | −20.83K | $19.66 | $409.58K | 5.9% | 355.28K | 334.45K |
| Total | −20.83K | -$409.58K | ||||||
Derivative Transactions0
No derivative transactions reported